Strata Skin科学 SSKN 深 沪
已收盘 09-12 16:00:00 美东时间
1.57
0.000
0.00%
华盛通- 最 高1.64
- 今 开1.57
- 成交量 17.82万股
- 最 低 1.52
- 昨 收 1.57
- 总市值 654.88万
- 52周最高 3.86
- 市盈率 静 --
- 换手率 4.27%
- 52周最低 1.52
- 委 比 -16.62%
- 总股本 417.12万
- 历史最高 3480.00
- 量 比 0.51
- 振 幅 7.64%
- 历史最低 1.52
- 每 手 1
- 风险率 1.05%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多STRATA Skin Sciences’ Elevate 360 Consulting Offering Drives Growth in Partner Clinic Operations and Fuels New Partnership Agreements
STRATA Skin Sciences introduces its Elevate 360 consulting platform, designed to optimize partner clinics' revenue through best practices in marketing, reimbursement, and patient retention. Since launching in early 2025, the program has driven a 7% year-over-year growth for participating clinics. A notable success involves a partner expanding from two to nine clinics, increasing revenue from $10,500 to $61,800 in six months. STRATA plans to lever...
09-04 12:15
Strata Skin Sciences Raises $2.4M in Stock Offering
Strata Skin Sciences ( ($SSKN) ) has shared an update. On September 2, 2025, St...
09-03 20:48
STRATA Skin Sciences Announces Pricing of $2.42 Million Registered Direct Offering of Common Stock Priced At-Market Under Nasdaq Rules
STRATA Skin Sciences, Inc. has entered into definitive agreements with institutional investors to sell 1,097,547 shares of common stock at $2.204 per share through a registered direct offering under Nasdaq rules. The offering is priced at-market and expected to close on September 4, 2025, subject to customary conditions. Gross proceeds to the Company are approximately $2.42 million, with net proceeds intended for working capital and general corpo...
09-03 12:00
Strata Skin Sciences shares are trading higher after the company announced that its patent portfolio provides intellectual property and market exclusivity for combination therapies of its XTRAC excimer laser when used with JAK inhibitor
Strata Skin Sciences shares are trading higher after the company announced that...
09-02 21:26
STRATA Skin Sciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference
STRATA Skin Sciences, Inc. announced that its CEO, Dr. Dolev Rafaeli, will present a corporate overview at the H.C. Wainwright 27th Annual Global Investment Conference on September 8-10, 2025, at the Lotte New York Palace Hotel. The presentation will be available on demand starting September 5, 2025, at 7:00am ET for registered investors. Strata Skin Sciences specializes in innovative dermatologic treatments, offering products like the XTRAC® exc...
09-02 20:05
STRATA Skin Sciences IP Portfolio Holds Exclusivity in Combination Therapies of Its XTRAC Excimer Laser with JAK Inhibitors, Systemic and Biologic Drugs, Bolstering Expansion into New Indications Like Vitiligo and Other Auto-Immune Skin Conditions
STRATA Skin Sciences announced the expansion of its patent portfolio to protect combination therapies using its XTRAC excimer laser with JAK inhibitors and biologic drugs, enhancing market exclusivity and growth opportunities. The company aims to include expanded CPT codes for all inflammatory and autoimmune skin conditions in the CMS physician fee schedule as early as January 1, 2026, significantly increasing patient reach and treatment economic...
09-02 12:05
Strata Skin Sciences Faces Nasdaq Compliance Notice
Strata Skin Sciences ( ($SSKN) ) just unveiled an update. On August 19, 2025, S...
08-23 05:00
Strata Skin Sciences Q2 EPS $(0.60) Misses $(0.29) Estimate, Sales $7.70M Miss $8.56M Estimate
Strata Skin Sciences (NASDAQ:SSKN) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.29) by 109.06 percent. This is a 1900 percent decrease over losses of $(0.03) per share
08-14 04:09
Earnings Scheduled For August 13, 2025
Companies Reporting Before The Bell • Evotec (NASDAQ:EVO) is projected to repor...
08-13 16:32
Preview: Strata Skin Sciences's Earnings
Strata Skin Sciences (NASDAQ:SSKN) is gearing up to announce its quarterly earn...
08-13 01:01
